Evaluation of a solid-phase immunoradiometric assay (IRMA) for serum thyroglobulin: effect of anti-thyroglobulin autoantibody
1982; Elsevier BV; Volume: 123; Issue: 3 Linguagem: Inglês
10.1016/0009-8981(82)90181-4
ISSN1873-3492
AutoresStefane Mariotti, Cristina Cupini, Claudio Giani, Riccardo Lari, Ermanno Rolled, Anthony Falco, Marino Marchisio, A Pinchera,
Tópico(s)Mass Spectrometry Techniques and Applications
ResumoThyroglobulin (Tg), the substrate of thyroid hormone production, is a tumor marker used in the surveillance of differentiated thyroid cancer. Measurement by immunoassay has become increasingly sensitive, providing a window into the presence of residual and recurrent disease. However, testing is plagued by the challenge of Tg autoantibodies present in a substantial portion of the cancer population. Assays utilizing liquid chromatography-tandem mass spectrometry circumvent this problem but are not free from potential hurdles. Here, we review the current clinical application of Tg measurement, the challenge posed by anti-Tg antibodies to standard immunometric platforms, and the development of mass spectrometry-based approaches. Efforts to harmonize (or assess harmonization) of newer methods and further improve sensitivity are discussed, as well as clinical workflows for using mass spectrometry alongside standard immunoassay testing.
Referência(s)